PPARG and Dravet syndrome: Hasan et al. hypothesized that the fibrosis-inhibiting effects of DS are mediated via the promotion of peroxisome proliferator-activated receptor-gamma (PPAR-γ) production and interaction with miR-17-5p, which triggers the Wnt-β-catenin pathway.